Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
SourceThe New England Journal of Medicine, 381, 9, (2019), pp. 841-851
Article / Letter to editor
Display more detailsDisplay less details
The New England Journal of Medicine
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.